Prestige Wealth Management Group’s West Pharmaceutical WST Stock Holding History

Prestige Wealth Management Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.59K	Buy	10 +3	+43%	+$917	﹤0.01%	653
2026 Q1	$1.75K	Sell	7 -2	-22%	-$498	﹤0.01%	766
2025 Q4	$2.48K	Hold	9	–	–	﹤0.01%	722
2025 Q3	$2.36K	Hold	9	–	–	﹤0.01%	709
2025 Q2	$1.97K	Buy	+9	New	+$1.92K	﹤0.01%	738
2024 Q3	–	Sell	-5	Closed	-$1.65K	–	1051
2024 Q2	$1.65K	Hold	5	–	–	﹤0.01%	758
2024 Q1	$1.98K	Hold	5	–	–	﹤0.01%	746
2023 Q4	$1.76K	Hold	5	–	–	﹤0.01%	769
2023 Q3	$1.88K	Hold	5	–	–	﹤0.01%	755
2023 Q2	$1.91K	Hold	5	–	–	﹤0.01%	768
2023 Q1	$1.73K	Sell	5 -6	-55%	-$1.75K	﹤0.01%	773
2022 Q4	$2.59K	Sell	11 -4	-27%	-$948	﹤0.01%	779
2022 Q3	$4K	Buy	15 +5	+50%	+$1.52K	﹤0.01%	631
2022 Q2	$3K	Sell	10 -8	-44%	-$2.6K	﹤0.01%	715
2022 Q1	$8K	Hold	18	–	–	﹤0.01%	521
2021 Q4	$8K	Sell	18 -3	-14%	-$1.29K	﹤0.01%	539
2021 Q3	$9K	Hold	21	–	–	﹤0.01%	515
2021 Q2	$8K	Buy	21 +3	+17%	+$991	﹤0.01%	534
2021 Q1	$5K	Buy	18 +1	+6%	+$286	﹤0.01%	639
2020 Q4	$5K	Hold	17	–	–	﹤0.01%	602
2020 Q3	$5K	Hold	17	–	–	﹤0.01%	552
2020 Q2	$4K	Sell	17 -5	-23%	-$982	﹤0.01%	578
2020 Q1	$3K	Buy	+22	New	+$3.39K	﹤0.01%	602
2019 Q1	–	Sell	-20	Closed	-$2K	–	1152
2018 Q4	$2K	Buy	+20	New	+$2.17K	﹤0.01%	894

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Prestige Wealth Management Group's WST Position: Q2 2026 in Review

Prestige Wealth Management Group increased its West Pharmaceutical (WST) stake by 43% in Q2 2026, buying an estimated $917 and bringing the position to 10 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Prestige Wealth Management Group first reported a position in WST in Q4 2018 and has held it in 24 quarters since. The position peaked at $9K in Q3 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Prestige Wealth Management Group held 10 shares of West Pharmaceutical worth $3.59K as of Q2 2026.
Prestige Wealth Management Group bought 3 West Pharmaceutical shares in Q2 2026, an estimated $917.
West Pharmaceutical made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #653 holding.
Prestige Wealth Management Group first reported a position in West Pharmaceutical in Q4 2018 and has held it in 24 quarters since.
Prestige Wealth Management Group's West Pharmaceutical position peaked at $9K in Q3 2021.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.